Scott Hofsess

3PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 29, 2024
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression.

Aditya Bardia, Hope S Rugo, Sara M Tolaney

|Nov 01, 2023
Improving Intracellular Delivery of an Antibody-Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses In Vivo.

Ian Nessler, Baron Rubahamya, Anna Kopp

|Oct 03, 2022
Antibody-Drug Conjugate Sacituzumab Govitecan Drives Efficient Tissue Penetration and Rapid Intracellular Drug Release.

Anna Kopp, Scott Hofsess, Thomas M Cardillo

Pageof 1

Frequent Collaborators

2 joint publications

Anna Kopp

2 joint publications

Thomas M Cardillo

2 joint publications

Serengulam V Govindan

2 joint publications

Jennifer Donnell